Insmed Inc. buy The Goldman Sachs Group, Inc.
Start price
29.05.24
/
50%
€46.00
Target price
29.05.25
€68.37
Performance (%)
33.70%
End price
30.05.25
€61.50
Summary
This prediction ended on 30.05.25 with a price of €61.50. With a performance of 33.70% the BUY prediction by The_Goldman_Sachs_Gr was a big success. The_Goldman_Sachs_Gr has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | 14.783% | 14.783% | 103.077% |
| iShares Core DAX® | 2.709% | 3.108% | 26.439% |
| iShares Nasdaq 100 | 0.867% | 4.580% | 16.075% |
| iShares Nikkei 225® | 3.135% | 7.481% | 10.283% |
| iShares S&P 500 | 0.886% | 3.550% | 10.377% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $49.00 to $74.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten